While strokes are known to increase risk for dementia, much less is known about diseases of large and small blood vessels in the brain, separate from stroke, and how they relate to dementia. Diseased blood vessels in the ...
Jul 1, 2016
0
585
A chemical in green tea has been shown to improve cognitive ability in persons with Down's syndrome, scientists and doctors said Tuesday.
Jun 7, 2016
1
1572
Withdrawing a commonly-prescribed Alzheimer's disease drug from people in the advanced stages of the disease doubles their risk of being placed in a nursing home within a year, according to UCL research published today in ...
Oct 27, 2015
0
108
A third of Alzheimer's disease cases worldwide can be attributed to risk facts that can be potentially modified, such as lack of education and physical inactivity, according to NIHR-funded research published in The Lancet ...
Jul 14, 2014
0
0
For years, scientists have attempted to understand how Alzheimer's disease harms the brain before memory loss and dementia are clinically detectable. Most researchers think this preclinical stage, which can last a decade ...
Sep 23, 2013
0
0
Uncontrolled high blood pressure damages the brain's structure and function as early as young middle-age, and even the brains of middle-aged people who clinically would not be considered to have hypertension have evidence ...
Oct 31, 2012
0
0
An inexpensive, five-minute eye scan can accurately assess the amount of brain damage in people with the debilitating autoimmune disorder multiple sclerosis (MS), and offer clues about how quickly the disease is progressing, ...
Oct 17, 2012
1
0
A team of Canadian scientists and clinicians, led by Dr. Michael Hill of the Calgary Stroke Program at Foothills Medical Centre and University of Calgary's Hotchkiss Brain Institute (HBI), have demonstrated that a neuroprotectant ...
Oct 9, 2012
1
0
Researchers from the University of Florida and 14 additional medical centers reported results today in the online version of The Lancet Neurology journal indicating that deep brain stimulation — also known as DBS — ...
Jan 11, 2012
0
0
The Lancet Neurology has published data from the phase 3 MycarinG study evaluating the efficacy and safety of rozanolixizumab in adult patients with acetylcholine receptor autoantibody-positive (AChR-Ab+) or muscle-specific ...
Apr 13, 2023
0
21
